非アルコール性脂肪性肝炎薬市場インサイト2019:世界及び中国の市場分析・予測

【英語タイトル】Non-Alcoholic Steatohepatitis Drug Market Insights 2019, Global and Chinese Analysis and Forecast to 2024

Prof Researchが出版した調査資料(PROF9J10525)・商品コード:PROF9J10525
・発行会社(調査会社):Prof Research
・発行日:2019年6月(※2024年版があります。お問い合わせください)
・ページ数:136
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル、中国
・産業分野:医療・製薬・バイオ
◆販売価格オプション(消費税別)
Single User(1名閲覧用)USD3,000 ⇒換算¥444,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD3,800 ⇒換算¥562,400見積依頼/購入/質問フォーム
Global Site License(複数事業所内共有可)USD5,000 ⇒換算¥740,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
世界及び中国における非アルコール性脂肪性肝炎薬市場について調査・分析したレポートで、非アルコール性脂肪性肝炎薬の世界市場動向、市場規模、主要企業情報などが含まれています。非アルコール性脂肪性肝炎薬の種類別・用途別に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。
・非アルコール性脂肪性肝炎薬産業の概要
・非アルコール性脂肪性肝炎薬の製造技術分析
・主要企業分析:企業概要、製品情報、連絡先など
・世界及び中国の非アルコール性脂肪性肝炎薬市場 2014年-2019年
・世界及び中国の非アルコール性脂肪性肝炎薬市場現状
・企業別分析:Genfit SA, Intercept Pharmaceuticals, Inc., Tobira Therapeutics, Inc., Galmed Pharmaceuticals Ltd.など
・地域別分析:アメリカ、ヨーロッパ、日本、中国など
・種類別分析、用途別分析
・世界及び中国の非アルコール性脂肪性肝炎薬市場予測 2019年-2024年
・非アルコール性脂肪性肝炎薬の産業チェーン分析
・世界及び中国のマクロ経済動向と影響
・世界及び中国の非アルコール性脂肪性肝炎薬市場動向・課題・機会
・新規プロジェクトへの提言・結論
【レポートの概要】

Non-Alcoholic Steatohepatitis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Non-Alcoholic Steatohepatitis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Non-Alcoholic Steatohepatitis Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Non-Alcoholic Steatohepatitis Drug market covering all important parameters.

The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Non-Alcoholic Steatohepatitis Drug industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Non-Alcoholic Steatohepatitis Drug industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Non-Alcoholic Steatohepatitis Drug Industry before evaluating its feasibility.

There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.

For competitor segment, the report includes global key players of Non-Alcoholic Steatohepatitis Drug as well as some small players. At least 4 companies are included:
* Genfit SA
* Intercept Pharmaceuticals
* Tobira Therapeutics
* Galmed Pharmaceuticals Ltd.

The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share

For product type segment, this report listed main product type of Non-Alcoholic Steatohepatitis Drug market in gloabal and china.
* Product Type I
* Product Type II
* Product Type III

For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Application I
* Application II
* Application III

Reasons to Purchase this Report:

* Estimates 2019-2024 Non-Alcoholic Steatohepatitis Drug market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.

Any special requirements about this report, please let us know and we can provide custom report.

【レポートの目次】

Chapter One Introduction of Non-Alcoholic Steatohepatitis Drug Industry
1.1 Brief Introduction of Non-Alcoholic Steatohepatitis Drug
1.2 Development of Non-Alcoholic Steatohepatitis Drug Industry
1.3 Status of Non-Alcoholic Steatohepatitis Drug Industry

Chapter Two Manufacturing Technology of Non-Alcoholic Steatohepatitis Drug
2.1 Development of Non-Alcoholic Steatohepatitis Drug Manufacturing Technology
2.2 Analysis of Non-Alcoholic Steatohepatitis Drug Manufacturing Technology
2.3 Trends of Non-Alcoholic Steatohepatitis Drug Manufacturing Technology

Chapter Three Analysis of Global Key Manufacturers
3.1 Genfit SA
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Intercept Pharmaceuticals
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Tobira Therapeutics
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Galmed Pharmaceuticals Ltd.
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Company E
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Company F
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Company G
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……

Chapter Four 2014-2019 Global and Chinese Market of Non-Alcoholic Steatohepatitis Drug
4.1 2014-2019 Global Capacity, Production and Production Value of Non-Alcoholic Steatohepatitis Drug Industry
4.2 2014-2019 Global Cost and Profit of Non-Alcoholic Steatohepatitis Drug Industry
4.3 Market Comparison of Global and Chinese Non-Alcoholic Steatohepatitis Drug Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Non-Alcoholic Steatohepatitis Drug
4.5 2014-2019 Chinese Import and Export of Non-Alcoholic Steatohepatitis Drug

Chapter Five Market Status of Non-Alcoholic Steatohepatitis Drug Industry
5.1 Market Competition of Non-Alcoholic Steatohepatitis Drug Industry by Company
5.2 Market Competition of Non-Alcoholic Steatohepatitis Drug Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Non-Alcoholic Steatohepatitis Drug Consumption by Application/Type

Chapter Six 2019-2024 Market Forecast of Global and Chinese Non-Alcoholic Steatohepatitis Drug Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Non-Alcoholic Steatohepatitis Drug
6.2 2019-2024 Non-Alcoholic Steatohepatitis Drug Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Non-Alcoholic Steatohepatitis Drug
6.4 2019-2024 Global and Chinese Supply and Consumption of Non-Alcoholic Steatohepatitis Drug
6.5 2019-2024 Chinese Import and Export of Non-Alcoholic Steatohepatitis Drug

Chapter Seven Analysis of Non-Alcoholic Steatohepatitis Drug Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry

Chapter Eight Global and Chinese Economic Impact on Non-Alcoholic Steatohepatitis Drug Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Non-Alcoholic Steatohepatitis Drug Industry

Chapter Nine Market Dynamics of Non-Alcoholic Steatohepatitis Drug Industry
9.1 Non-Alcoholic Steatohepatitis Drug Industry News
9.2 Non-Alcoholic Steatohepatitis Drug Industry Development Challenges
9.3 Non-Alcoholic Steatohepatitis Drug Industry Development Opportunities

Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment

Chapter Eleven Research Conclusions of Global and Chinese Non-Alcoholic Steatohepatitis Drug Industry

Tables and Figures
Figure Non-Alcoholic Steatohepatitis Drug Product Picture
Table Development of Non-Alcoholic Steatohepatitis Drug Manufacturing Technology
Figure Manufacturing Process of Non-Alcoholic Steatohepatitis Drug
Table Trends of Non-Alcoholic Steatohepatitis Drug Manufacturing Technology
Figure Non-Alcoholic Steatohepatitis Drug Product and Specifications
Table 2014-2019 Non-Alcoholic Steatohepatitis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Production Global Market Share
Figure Non-Alcoholic Steatohepatitis Drug Product and Specifications
Table 2014-2019 Non-Alcoholic Steatohepatitis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Production Global Market Share
Figure Non-Alcoholic Steatohepatitis Drug Product and Specifications
Table 2014-2019 Non-Alcoholic Steatohepatitis Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Production Global Market Share
Figure Non-Alcoholic Steatohepatitis Drug Product and Specifications
Table 2014-2019 Non-Alcoholic Steatohepatitis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Production Global Market Share
Figure Non-Alcoholic Steatohepatitis Drug Product and Specifications
Table 2014-2019 Non-Alcoholic Steatohepatitis Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Production Global Market Share
Figure Non-Alcoholic Steatohepatitis Drug Product and Specifications
Table 2014-2019 Non-Alcoholic Steatohepatitis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Production Global Market Share
Figure Non-Alcoholic Steatohepatitis Drug Product and Specifications
Table 2014-2019 Non-Alcoholic Steatohepatitis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Production Global Market Share
Figure Non-Alcoholic Steatohepatitis Drug Product and Specifications
Table 2014-2019 Non-Alcoholic Steatohepatitis Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-Alcoholic Steatohepatitis Drug Production Global Market Share
……
……
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Capacity List
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Manufacturers Capacity Share List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Manufacturers Capacity Share
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Manufacturers Production List
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Manufacturers Production Share List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Manufacturers Production Share
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Manufacturers Production Value List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Production Value and Growth Rate
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Manufacturers Production Value Share List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Manufacturers Production Value Share
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Non-Alcoholic Steatohepatitis Drug Production
Table 2014-2019 Global Supply and Consumption of Non-Alcoholic Steatohepatitis Drug
Table 2014-2019 Import and Export of Non-Alcoholic Steatohepatitis Drug
Figure 2018 Global Non-Alcoholic Steatohepatitis Drug Key Manufacturers Capacity Market Share
Figure 2018 Global Non-Alcoholic Steatohepatitis Drug Key Manufacturers Production Market Share
Figure 2018 Global Non-Alcoholic Steatohepatitis Drug Key Manufacturers Production Value Market Share
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Capacity List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Capacity
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Capacity Share List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Capacity Share
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Production List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Production
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Production Share List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Production Share
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Consumption Volume List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Consumption Volume
Table 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Consumption Volume Share List
Figure 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Consumption Volume Market by Application
Table 89 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Non-Alcoholic Steatohepatitis Drug Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Non-Alcoholic Steatohepatitis Drug Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Non-Alcoholic Steatohepatitis Drug Consumption Volume Market by Application
Figure 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Capacity Production and Growth Rate
Figure 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Production Value and Growth Rate
Table 2019-2024 Global Non-Alcoholic Steatohepatitis Drug Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Non-Alcoholic Steatohepatitis Drug Production
Table 2019-2024 Global Supply and Consumption of Non-Alcoholic Steatohepatitis Drug
Table 2019-2024 Import and Export of Non-Alcoholic Steatohepatitis Drug
Figure Industry Chain Structure of Non-Alcoholic Steatohepatitis Drug Industry
Figure Production Cost Analysis of Non-Alcoholic Steatohepatitis Drug
Figure Downstream Analysis of Non-Alcoholic Steatohepatitis Drug
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Non-Alcoholic Steatohepatitis Drug Industry
Table Non-Alcoholic Steatohepatitis Drug Industry Development Challenges
Table Non-Alcoholic Steatohepatitis Drug Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Non-Alcoholic Steatohepatitis Drugs Project Feasibility Study



【掲載企業】

Genfit SA, Intercept Pharmaceuticals, Inc., Tobira Therapeutics, Inc., Galmed Pharmaceuticals Ltd.

★調査レポート[非アルコール性脂肪性肝炎薬市場インサイト2019:世界及び中国の市場分析・予測] (コード:PROF9J10525)販売に関する免責事項を必ずご確認ください。
★調査レポート[非アルコール性脂肪性肝炎薬市場インサイト2019:世界及び中国の市場分析・予測]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆